Medicure Ownership
| MCUJF Stock | USD 0.58 0.12 17.14% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Medicure |
Medicure Pink Sheet Ownership Analysis
About 27.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.57. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medicure had not issued any dividends in recent years. The entity had 1:15 split on the 2nd of November 2012. Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada. Medicure is traded on OTC Exchange in the United States.The quote for Medicure is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Medicure contact Albert Friesen at 204 487 7412 or learn more at https://www.medicure.com.Currently Active Assets on Macroaxis
Other Information on Investing in Medicure Pink Sheet
Medicure financial ratios help investors to determine whether Medicure Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicure with respect to the benefits of owning Medicure security.